NJBIA opposes bill setting price controls on NJ Pharma companies

By InsideNJ.com
| May 25, 2022

A bill that would place price controls on the pharmaceutical industry, rather than taking a system-wide approach to address consumer cost concerns, is being opposed by the New Jersey Business & Industry Association.

Full story

#1

Physicians are in short supply. They are costly. Is the APP the answer to the CMO's workforce and budget challenges? ...

Amid the hype and promise, a growing tension is becoming clear: the reality of what AI can deliver versus what it can't. ...